# Impact of Semaglutide on Kidney, Cardiovascular, and Mortality Outcomes by Baseline BMI and Weight Loss in People with T2D and CKD—Data from the FLOW Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/impact-of-semaglutide-on-kidney-cardiovascular-and-mortality-outcomes-by/

## Facts

| Field | Value |
| --- | --- |
| Author Names | R E Schmieder,K R Tuttle,R E Pratley,K W Mahaffey,M Arici,N Belmar,K Bonefeld,G Chernin,R Correa-Rotter,P Gillard,S Hadjadj,T Idorn,L Ji,M Linder,M Shamkhalova,A Sriwijitkamol,V Perkovic,P Rossing,JF. E. Mann |
| Citations | 0 |
| DOI | 10.1055/s-0046-1820050 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7160139916 |
| Type | conference-abstract |
| Year | 2026 |

## Paper authors

- [V Perkovic](https://scholariq.org/researchers/v-perkovic/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.